348 results
Death and myocardial infarction following initial revascularization vs optimal medical therapy in chronic coronary syndromes with myocardial ischemia
16 Feb 2021
A systematic review and meta-analysis of contemporary randomized controlled trials published in the JAHA, interpreted using a standardized two-step approach: PICOT and SWOT
What you need to know about DAPT in high-bleeding risk patients
12 Dec 2020 – From GulfPCR-GIM 2020
This educational session focuses on the high-bleeding risk situation in the Gulf Region, the latest evidence on HBR and how to integrate it into your practice, followed by challenging cases discussed by Mirvat Alasnag,Thomas Cuisset, Marco Valgimigli and Peter Smits.
CAD management in TAVI patients
12 Dec 2020 – From GulfPCR-GIM 2020
Watch this session if you want to reflect on optimal management of CAD in TAVI candidates, to discuss tips and tricks to improve future coronary access during TAVI procedure and to review how to optimise management of CAD in post-TAVI patients.
This session was originally presented during...
The year in review in Interventional Cardiology: clinical trials and relevant literature published in 2020
12 Dec 2020 – From GulfPCR-GIM 2020
Watch this session if you want to reflect on key learnings for clinical practice from selected trials published in 2020, to get a rapid overview of the most relevant literature of the year in the fields of coronary, valvular and peripheral interventions and to see examples...
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial
27 Nov 2020
The ALPHEUS study sought to investigate whether more potent and rapid platelet inhibition properties of ticagrelor could reduce periprocedural atherothrombotic complications in chronic coronary syndrome patients undergoing high-risk PCI.
Reviewer
Tony Gershlick - A tribute from South Africa
24 Nov 2020
On behalf of the whole PCR Community, William Wijns and Jean Fajadet, Chairmen of PCR, extend their condolences upon the loss of Tony Gershlick. Read this tribute to an exceptional teacher and mentor in interventional cardiology by Farrel Hellig and David Kettles.
Author
Author
Best of #AHA20 Interventional Trials
19 Nov 2020
Mirvat Al Asnag provides reviews and take-home messages from a selection of major Late-breaking Clinical Trials in Interventional Cardiology released at the 2020 virtual edition of the American Heart Association Congress.
Author
Editorial - The “Interventional cardiac surgeon”: the (new) member of the interventional Heart Team
18 Nov 2020
Surgeons have been for many years the only interventionalists. The only “doctors” to dare enter the body and mechanically intervene on structures to cure or improve quality of life. The link between surgeons and interventional cardiologists is very strong. Many surgeons contributed to the development of...
Author
Author
Author
Initial invasive versus conservative management of stable ischemic heart disease in patients with a history of heart failure or left ventricular dysfunction
03 Dec 2020
Insights from the ISCHEMIA Trial, commented by D. Milasinovic
Reviewer
Aspirin-free prasugrel monotherapy following coronary artery stenting in patients with stable CAD
27 Oct 2020
The ASET pilot study: a multicenter, single-arm, first-in-human and proof-of-concept trial which included a total of 212 low-risk patients with stable coronary artery disease
Reviewer
